New Strong Buy Stocks for November 12th

Zacks
2024-11-12

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Grupo Financiero Galicia S.A. GGAL: This financial service holding company has seen the Zacks Consensus Estimate for its current year earnings increasing 8.4% over the last 60 days.

Grupo Financiero Galicia S.A. Price and Consensus

Grupo Financiero Galicia S.A. price-consensus-chart | Grupo Financiero Galicia S.A. Quote

Gold Fields Limited GFI: This gold mining company has seen the Zacks Consensus Estimate for its current year earnings increasing 9.8% over the last 60 days.

Gold Fields Limited Price and Consensus

Gold Fields Limited price-consensus-chart | Gold Fields Limited Quote

Fulcrum Therapeutics, Inc. FULC: This clinical-stage biopharmaceutical company has seen the Zacks Consensus Estimate for its current year earnings increasing 39.1% over the last 60 days.

Fulcrum Therapeutics, Inc. Price and Consensus

Fulcrum Therapeutics, Inc. price-consensus-chart | Fulcrum Therapeutics, Inc. Quote

Deckers Outdoor Corporation DECK: This footwear and apparel company has seen the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 60 days.

Deckers Outdoor Corporation Price and Consensus

Deckers Outdoor Corporation price-consensus-chart | Deckers Outdoor Corporation Quote

New Gold Inc. NGD: This gold mining company has seen the Zacks Consensus Estimate for its current year earnings increasing 30.8% over the last 60 days.

New Gold Inc. Price and Consensus

New Gold Inc. price-consensus-chart | New Gold Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Deckers Outdoor Corporation (DECK) : Free Stock Analysis Report

Gold Fields Limited (GFI) : Free Stock Analysis Report

New Gold Inc. (NGD) : Free Stock Analysis Report

Grupo Financiero Galicia S.A. (GGAL) : Free Stock Analysis Report

Fulcrum Therapeutics, Inc. (FULC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10